Home › Asset managers › Blackstone Alternative Investment Funds › 2025-2026 › Against the board
Two kinds of vote are listed: a board-sponsored proposal Blackstone Alternative Investment Funds voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
1,316 proposals.
| Company | Meeting | Proposal | Category | On the ballot from | Board recommended | Blackstone Alternative Investment Funds voted | Funds |
|---|---|---|---|---|---|---|---|
| Bilibili, Inc. | June 17, 2026 | Approve PricewaterhouseCoopers and PricewaterhouseCoopers Zhong Tian LLP as Auditors and Authorize Board to Fix Their Remuneration | Audit-related | Board | AGAINST | 1 | |
| Bilibili, Inc. | June 17, 2026 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 1 | |
| BioCardia, Inc. | December 2, 2025 | To approve the extension amendment and restatement of our 2016 Equity Incentive Plan (the "2016 Plan") to (i) extend the term of our 2016 Plan until October 31, 2035, (ii) change the automatic share reserve increase pursuant to our 2016 Plan to automatically increase the number of shares available for issuance under the 2016 Plan on the date of this Annual Meeting and the first day of each fiscal year following this Annual Meeting, in an amount equal to, subject to the limitations in the 2016 Plan, four percent (4.0%) of the outstanding shares on the day immediately preceding each automatic increase, and (iii) limit the portion of the share reserve available for issuance pursuant to the exercise of incentive stock options. A vote to "ABSTAIN" will have the same effect as a vote "AGAINST" the proposal. | Compensation | Board | AGAINST | 1 | |
| BioCryst Pharmaceuticals, Inc. | June 11, 2026 | To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| BioCryst Pharmaceuticals, Inc. | June 11, 2026 | To hold a non-binding, advisory vote regarding executive compensation. | Say-on-Pay | Board | AGAINST | 1 | |
| BioNTech SE | May 15, 2026 | Approve Remuneration Report | Compensation | Board | AGAINST | 1 | |
| BioNTech SE | May 15, 2026 | Elect Iris Loew-Friedrich to the Supervisory Board | Director Elections | Board | AGAINST | 1 | |
| BioNexus Gene Lab Corp. | December 24, 2025 | Approval of the 2025 Equity Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| Biohaven Ltd. | April 28, 2026 | Election of Directors for a term expiring at the 2029 Annual Meeting of shareholders: Michael T. Heffernan | Director Elections | Board | AGAINST | 1 | |
| Biomea Fusion, Inc. | June 10, 2026 | The election of Rainer (Ramses) Erdtmann and Eric Aguiar, M.D., as Class II Directors, to serve for a three-year term ending at the Annual Meeting of Stockholders to be held in 2029: Rainer (Ramses) Erdtmann | Director Elections | Board | WITHHOLD | 1 | |
| Black Rock Coffee Bar, Inc. | May 27, 2026 | The election of Class I directors: Jeff Hernandez | Director Elections | Board | WITHHOLD | 1 | |
| Bloom Energy Corporation | May 21, 2026 | Election of our four Class II Directors: Barbara Burger | Director Elections | Board | WITHHOLD | 1 | |
| Bloom Energy Corporation | May 21, 2026 | Election of our four Class II Directors: Eddy Zervigon | Director Elections | Board | WITHHOLD | 1 | |
| Blue Owl Capital Inc. | June 4, 2026 | Election of Directors: Claudia Holz | Director Elections | Board | AGAINST | 1 | |
| Blue Owl Capital Inc. | June 4, 2026 | Election of Directors: Marc S. Lipschultz | Director Elections | Board | AGAINST | 1 | |
| Blue Owl Capital Inc. | June 4, 2026 | Election of Directors: Michael D. Rees | Director Elections | Board | AGAINST | 1 | |
| Blue Owl Technology Finance Corp. | June 25, 2026 | To elect each of Eric Kaye and Victor Woolridge to the board of directors of Blue Owl Technology Finance Corp. (the "Company") for three-year terms, each expiring at the 2029 annual meeting of shareholders and until their successors are duly elected and qualified: Eric Kaye | Director Elections | Board | AGAINST | 1 | |
| Blue Ridge Bankshares, Inc. | June 17, 2026 | To elect five Company directors for a term of one year each: Anthony R. Scavuzzo Term expiring in 2027 | Director Elections | Board | WITHHOLD | 1 | |
| BlueLinx Holdings Inc. | May 14, 2026 | Election of Directors: Mitchell B. Lewis | Director Elections | Board | AGAINST | 1 | |
| BlueLinx Holdings Inc. | May 14, 2026 | Proposal to approve an Amendment to the 2021 Long-Term Incentive Plan to increase the number of shares of common stock reserved for issuance under the plan. | Compensation | Board | AGAINST | 1 | |
| Boston Omaha Corporation | August 25, 2025 | Election of Directors (other than the Class B common stock Director): Frank H. Kenan II | Director Elections | Board | WITHHOLD | 1 | |
| Boston Omaha Corporation | August 25, 2025 | Election of Directors (other than the Class B common stock Director): Thomas Burt | Director Elections | Board | WITHHOLD | 1 | |
| Boston Omaha Corporation | August 25, 2025 | Election of Directors (other than the Class B common stock Director): Vishnu Srinivasan | Director Elections | Board | WITHHOLD | 1 | |
| Bowhead Specialty Holdings Inc. | April 30, 2026 | Election of Directors: David Holman | Director Elections | Board | WITHHOLD | 1 | |
| Box, Inc. | June 25, 2026 | Election of Directors: Jack Lazar | Director Elections | Board | AGAINST | 1 | |
| Box, Inc. | June 25, 2026 | Election of Directors: Steve Murphy | Director Elections | Board | AGAINST | 1 | |
| Box, Inc. | June 25, 2026 | Election of Directors: Sue Barsamian | Director Elections | Board | AGAINST | 1 | |
| Box, Inc. | June 25, 2026 | To approve an amendment to our Amended and Restated 2015 Equity Incentive Plan to increase the number of shares reserved for issuance by 7,200,000 shares. | Compensation | Board | AGAINST | 1 | |
| Brandywine Realty Trust | May 28, 2026 | Adoption of an amendment to the 2023 Long-Term Incentive Plan to increase the term of the plan and the number of the common shares that may be issued thereunder. | Compensation | Board | AGAINST | 1 | |
| BridgeBio Pharma, Inc. | June 22, 2026 | To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 2,000,000 shares. | Compensation | Board | AGAINST | 1 | |
| Bridgewater Bancshares, Inc. | April 28, 2026 | Approve the Bridgewater Bancshares, Inc. 2026 Equity Incentive Plan; and | Compensation | Board | AGAINST | 1 | |
| BrightSpring Health Services, Inc. | May 21, 2026 | Election of Class II directors: Olivia Kirtley | Director Elections | Board | WITHHOLD | 1 | |
| BrightSpring Health Services, Inc. | May 21, 2026 | Election of Class II directors: Steve Miller | Director Elections | Board | WITHHOLD | 1 | |
| BrightView Holdings, Inc. | March 3, 2026 | Election of Directors: James R. Abrahamson | Director Elections | Board | WITHHOLD | 1 | |
| Broadcom Inc. | April 20, 2026 | Advisory vote to approve the named executive officer compensation. | Say-on-Pay | Board | AGAINST | 1 | |
| Brookfield Business Corporation | June 18, 2026 | Elect Director Cyrus Madon | Director Elections | Board | WITHHOLD | 1 | |
| Brookfield Business Corporation | June 18, 2026 | Elect Director Jeffrey Blidner | Director Elections | Board | WITHHOLD | 1 | |
| Brookfield Business Corporation | June 18, 2026 | Elect Director Lori Pearson | Director Elections | Board | WITHHOLD | 1 | |
| Brookfield Business Corporation | June 18, 2026 | Elect Director Stephen Girsky | Director Elections | Board | WITHHOLD | 1 | |
| Bumble Inc. | June 4, 2026 | Approval, on a non-binding advisory basis, of the compensation of the named executive officers as disclosed in the Proxy Statement. | Say-on-Pay | Board | AGAINST | 1 | |
| Butterfly Network, Inc. | June 18, 2026 | To approve by a non-binding advisory vote the compensation of the Company's named executive officers, as disclosed in the proxy statement. | Say-on-Pay | Board | AGAINST | 1 | |
| C4 Therapeutics, Inc. | June 24, 2026 | To approve an amendment to our 2020 Stock Option and Incentive Plan to amend the evergreen provision to include any outstanding pre-funded warrants in the total number of shares of common stock that are issued and outstanding as of each December 31. | Compensation | Board | AGAINST | 1 | |
| C4 Therapeutics, Inc. | June 24, 2026 | To elect three Class III directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Stockholders and until his/her successor has been duly elected and qualified, or until his/her earlier resignation or removal: Andrew Hirsch | Director Elections | Board | WITHHOLD | 1 | |
| CEVA, Inc. | June 2, 2026 | Advisory vote to approve named executive officer compensation | Say-on-Pay | Board | AGAINST | 1 | |
| CION Investment Corporation | July 28, 2025 | To elect three directors of the Company, who will each serve for a term of three years expiring in 2028, or until their successors are duly elected and qualified (the "Class I Director Proposal"): Edward J. Estrada | Director Elections | Board | WITHHOLD | 1 | |
| CMB.TECH NV | May 21, 2026 | Approve Remuneration Policy | Compensation | Board | AGAINST | 1 | |
| CMB.TECH NV | May 21, 2026 | Approve Remuneration Report | Compensation | Board | AGAINST | 1 | |
| CMB.TECH NV | May 21, 2026 | Reelect Debemar BV, Permanently Represented by Patrick De Brabandere, as Member of the Supervisory Board | Director Elections | Board | AGAINST | 1 | |
| CNA Financial Corporation | April 29, 2026 | An advisory (non-binding) vote to approve named executive officer compensation. | Say-on-Pay | Board | AGAINST | 1 | |
| CNA Financial Corporation | April 29, 2026 | Election to the Board of the ten nominees named below: Andrew H. Tisch | Director Elections | Board | WITHHOLD | 1 | |
| CNA Financial Corporation | April 29, 2026 | Election to the Board of the ten nominees named below: Benjamin J. Tisch | Director Elections | Board | WITHHOLD | 1 | |
| CNA Financial Corporation | April 29, 2026 | Election to the Board of the ten nominees named below: Douglas M. Worman | Director Elections | Board | WITHHOLD | 1 | |
| CNA Financial Corporation | April 29, 2026 | Election to the Board of the ten nominees named below: James S. Tisch | Director Elections | Board | WITHHOLD | 1 | |
| CNA Financial Corporation | April 29, 2026 | Election to the Board of the ten nominees named below: Jane J. Wang | Director Elections | Board | WITHHOLD | 1 | |
| CNA Financial Corporation | April 29, 2026 | Election to the Board of the ten nominees named below: Kenneth I. Siegel | Director Elections | Board | WITHHOLD | 1 | |
| CRISPR Therapeutics AG | June 4, 2026 | Approval of the CRISPR Therapeutics AG 2026 Stock Option and Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| CRISPR Therapeutics AG | June 4, 2026 | Binding vote on maximum equity for members of the Board of Directors from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders. | Compensation | Board | AGAINST | 1 | |
| CRISPR Therapeutics AG | June 4, 2026 | Binding vote on maximum equity for members of the Executive Committee from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders. | Compensation | Board | AGAINST | 1 | |
| CRISPR Therapeutics AG | June 4, 2026 | Binding vote on maximum non-performance-related compensation for members of the Executive Committee from July 1, 2026 to June 30, 2027. | Compensation | Board | AGAINST | 1 | |
| CRISPR Therapeutics AG | June 4, 2026 | Binding vote on maximum variable compensation for members of the Executive Committee for the current year ending December 31, 2026. | Compensation | Board | AGAINST | 1 | |
| CRISPR Therapeutics AG | June 4, 2026 | Non-binding advisory vote on the 2025 Compensation Report. | Compensation | Board | AGAINST | 1 | |
| CRISPR Therapeutics AG | June 4, 2026 | Non-binding advisory vote on the compensation paid to the Company's named executive officers under U.S. securities law requirements. | Say-on-Pay | Board | AGAINST | 1 | |
| CRISPR Therapeutics AG | June 4, 2026 | Re-election of Ali Behbahani, M.D. | Director Elections | Board | AGAINST | 1 | |
| CRISPR Therapeutics AG | June 4, 2026 | Re-election of the members of the Compensation Committee: Re-election of Ali Behbahani, M.D. | Director Elections | Board | AGAINST | 1 | |
| CVR Energy, Inc. | June 4, 2026 | To approve, on an advisory basis, our named executive officer compensation. | Say-on-Pay | Board | AGAINST | 1 | |
| Cabaletta Bio, Inc. | June 9, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 1 | |
| Cabaletta Bio, Inc. | June 9, 2026 | To elect two class I directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Scott Brun, M.D. | Director Elections | Board | WITHHOLD | 1 | |
| Can-Fite BioPharma Ltd. | March 3, 2026 | Approve Renewed Compensation Policy for the Directors and Officers of the Company | Compensation | Board | AGAINST | 1 | |
| Can-Fite BioPharma Ltd. | May 28, 2026 | Approve Grant of Options to Motti Farbstein, CEO and CFO | Compensation | Board | AGAINST | 1 | |
| Can-Fite BioPharma Ltd. | May 28, 2026 | Approve Grant of Options to Pnina Fishman, Chairwoman | Compensation | Board | AGAINST | 1 | |
| Canada Goose Holdings Inc. | August 8, 2025 | Elect Director Dani Reiss | Director Elections | Board | WITHHOLD | 1 | |
| Canada Goose Holdings Inc. | August 8, 2025 | Elect Director Ryan Cotton | Director Elections | Board | WITHHOLD | 1 | |
| Canadian Pacific Kansas City Limited | April 29, 2026 | Advisory Vote on Executive Compensation Approach | Compensation | Board | AGAINST | 1 | |
| Capital Southwest Corporation | July 24, 2025 | To approve, on an advisory basis, the compensation of Capital Southwest Corporation's named executive officers. | Say-on-Pay | Board | AGAINST | 1 | |
| Cardiff Oncology, Inc. | June 11, 2026 | Proposal to approve an amendment to the Company's 2021 Omnibus Equity Incentive Plan to increase the number of shares issuable thereunder to 15,150,000 shares from 12,150,000 shares. | Compensation | Board | AGAINST | 1 | |
| Cardiol Therapeutics Inc. | June 24, 2026 | Elect Director Guillermo Torre-Amione | Director Elections | Board | WITHHOLD | 1 | |
| Cardiol Therapeutics Inc. | June 24, 2026 | Elect Director Jennifer Chao | Director Elections | Board | WITHHOLD | 1 | |
| Cardiol Therapeutics Inc. | June 24, 2026 | Elect Director Peter Pekos | Director Elections | Board | WITHHOLD | 1 | |
| CareCloud, Inc. | June 4, 2026 | Approval of the 2026 Equity Incentive Plan: | Compensation | Board | AGAINST | 1 | |
| CareCloud, Inc. | June 4, 2026 | Election of Directors: Cameron Munter | Director Elections | Board | WITHHOLD | 1 | |
| CareDx, Inc. | June 11, 2026 | Approval of an amendment to the 2024 Equity Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| Caribou Biosciences, Inc. | June 17, 2026 | To elect three Class II directors to serve until the Company's 2029 annual meeting of stockholders and until their respective successors are duly elected and qualified or until their earlier death, resignation or removal. The three nominees for election are: Andrew Guggenhime, M.B.A. | Director Elections | Board | WITHHOLD | 1 | |
| Carriage Services, Inc. | May 12, 2026 | Approve our proposed Second Amendment to the Company's 2017 Omnibus Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| Cartesian Therapeutics, Inc. | June 12, 2026 | Election of Directors: Michael Singer, M.D., Ph.D. | Director Elections | Board | WITHHOLD | 1 | |
| Cartesian Therapeutics, Inc. | June 12, 2026 | Election of Directors: Patrick Zenner, MBA | Director Elections | Board | WITHHOLD | 1 | |
| Cartesian Therapeutics, Inc. | June 12, 2026 | Election of Directors: Timothy A. Springer, Ph.D. | Director Elections | Board | WITHHOLD | 1 | |
| Castle Biosciences, Inc. | May 28, 2026 | To elect the three Class I director nominees listed below to hold office until the 2029 Annual Meeting of Stockholders: Ellen Goldberg | Director Elections | Board | WITHHOLD | 1 | |
| Cellebrite DI Ltd. | September 19, 2025 | Approve Compensation Package for Thomas E. Hogan, CEO | Compensation | Board | AGAINST | 1 | |
| Centrais Eletricas Brasileiras SA | April 15, 2026 | Approve Performance Share Plan | Compensation | Board | AGAINST | 1 | |
| Central Bancompany, Inc. | May 4, 2026 | Election of Directors: E. Stanley Kroenke Class I director | Director Elections | Board | AGAINST | 1 | |
| Centuri Holdings, Inc. | May 19, 2026 | Election of Directors: Anne L. Mariucci | Director Elections | Board | WITHHOLD | 1 | |
| Century Therapeutics, Inc. | June 11, 2026 | Election of Class II directors for a three year term expiring in 2029: Alessandro Riva, M.D. | Director Elections | Board | WITHHOLD | 1 | |
| Ceragon Networks Ltd. | June 11, 2026 | Approve Certain Compensation Terms of Doron Arazi, CEO | Compensation | Board | AGAINST | 1 | |
| Ceragon Networks Ltd. | June 11, 2026 | Approve Renewal of Compensation Policy for the Executives and Directors of the Company Including Certain Amendments | Compensation | Board | AGAINST | 1 | |
| Cerence Inc. | February 12, 2026 | Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers, as disclosed in the proxy statement. | Say-on-Pay | Board | AGAINST | 1 | |
| Ceribell, Inc. | June 2, 2026 | Election of Directors: Josef Parvizi, M.D., Ph.D. | Director Elections | Board | WITHHOLD | 1 | |
| Ceribell, Inc. | June 2, 2026 | Election of Directors: Rebecca Robertson | Director Elections | Board | WITHHOLD | 1 | |
| Cerus Corporation | June 2, 2026 | The approval of an amendment and restatement of the Company's 2024 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance thereunder by 10 million shares and to make certain other changes thereto as described further in the accompanying Proxy Statement. | Compensation | Board | AGAINST | 1 | |
| Chemed Corporation | May 18, 2026 | Advisory vote to approve executive compensation. | Say-on-Pay | Board | AGAINST | 1 | |
| Chewy, Inc. | July 10, 2025 | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. | Say-on-Pay | Board | AGAINST | 1 |
← Previous Page 3 of 14 Next →
← Back to Blackstone Alternative Investment Funds 2025-2026 overview
Built October 18, 2026 from SEC Form N-PX filings.